Effects of sex steroid hormones on pancreatic cancer in the rat
- PMID: 2081921
- DOI: 10.1007/BF02924233
Effects of sex steroid hormones on pancreatic cancer in the rat
Abstract
The incidence of spontaneous and induced neoplasms of the exocrine pancreas in rats is higher in males than in females. Castration, ovariectomy, and hormone replacement with estradiol and testosterone have been shown to influence the growth of carcinogen-induced preneoplastic foci in the azaserine-rat model of pancreatic carcinogenesis. Similar hormonal treatments have also influenced the growth of an azaserine-induced poorly differentiated acinar cell carcinoma that can be transplanted syngeneically in Lewis rats. The effect on growth of preneoplastic lesions and carcinomas is similar. The preneoplastic lesions and transplanted tumors grow faster in intact male rats than in castrated rats, and the growth of the lesions and tumors is inhibited by estrogen treatment. It appears that testosterone supports the growth of preneoplastic foci and carcinomas, whereas estrogen inhibits such growth. The mechanism is unknown and may be direct, or an indirect effect may be mediated through a peptide hormone. Tamoxifen treatment did not significantly influence the growth of the transplanted carcinomas in the rat model.
Similar articles
-
Effect of orchiectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat.Pancreas. 1987;2(1):38-43. doi: 10.1097/00006676-198701000-00006. Pancreas. 1987. PMID: 3494994
-
Effect of castration and hormone replacement on azaserine-induced pancreatic carcinogenesis in male and female Fischer rats.Carcinogenesis. 1987 May;8(5):699-703. doi: 10.1093/carcin/8.5.699. Carcinogenesis. 1987. PMID: 3581428
-
Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine.Cancer Res. 1989 May 1;49(9):2332-6. Cancer Res. 1989. PMID: 2706621
-
Early indicators of exocrine pancreas carcinogenesis produced by non-genotoxic agents.Mutat Res. 1991 Jun;248(2):291-302. doi: 10.1016/0027-5107(91)90063-t. Mutat Res. 1991. PMID: 2046686 Review.
-
Hormones and pancreatic cancer.Int J Pancreatol. 1991 Summer;9:81-6. doi: 10.1007/BF02925582. Int J Pancreatol. 1991. PMID: 1744451 Review.
Cited by
-
Gender-related differentially expressed genes in pancreatic cancer: possible culprits or accomplices?Front Genet. 2022 Oct 26;13:966941. doi: 10.3389/fgene.2022.966941. eCollection 2022. Front Genet. 2022. PMID: 36386839 Free PMC article.
-
Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.Int J Pancreatol. 1993 Jun;13(3):159-68. doi: 10.1007/BF02924436. Int J Pancreatol. 1993. PMID: 8103783 Review.
-
Gender differences in chemical carcinogenesis in National Toxicology Program 2-year bioassays.Toxicol Pathol. 2012 Dec;40(8):1160-8. doi: 10.1177/0192623312446527. Epub 2012 May 14. Toxicol Pathol. 2012. PMID: 22585941 Free PMC article.
-
Human pancreas-specific protein disulfide isomerase homolog (PDIp) is an intracellular estrogen-binding protein that modulates estrogen levels and actions in target cells.J Steroid Biochem Mol Biol. 2009 May;115(1-2):20-9. doi: 10.1016/j.jsbmb.2009.02.008. Epub 2009 Feb 21. J Steroid Biochem Mol Biol. 2009. PMID: 19429457 Free PMC article.
-
Association of Menopausal Hormone Therapy with Risk of Pancreatic Cancer: A Systematic Review and Meta-analysis of Cohort Studies.Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):114-122. doi: 10.1158/1055-9965.EPI-22-0518. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36306390 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical